KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
1.82
+0.13 (+7.69%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close1.69
Open1.75
Bid1.89 x 0
Ask1.89 x 0
Day's Range1.72 - 1.99
52 Week Range0.87 - 1.99
Volume2,121,030
Avg. Volume439,277
Market Cap108.171M
Beta-0.12
PE Ratio (TTM)N/A
EPS (TTM)-0.34
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group13 days ago

    Khiron Life Sciences Corp. to Present at Virtual Investor Conference

    Live Webcast Scheduled for September 12, 2018 , 2:00pm EDT , followed by Q&A TORONTO , Sept. 12, 2018 /CNW/ --  KHIRON LIFE SCIENCES CORP. ("Khiron" or the "Company") (TSXV: KHRN, OTCQB: ...

  • CNW Group13 days ago

    Khiron announces closing of $12.93 million prospectus financing including full exercise of over-allotment option

    TORONTO, Sept. 12, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a Canadian integrated medical cannabis company with its core operations in Colombia, is pleased to announce that it has closed today its previously announced best efforts short form prospectus offering of common shares ("Common Shares"), including the exercise in full of the over-allotment option (the "Offering"). A total of 14,375,000 Common Shares were sold at a price of $0.90 per Common Share (the "Issue Price") for aggregate gross proceeds of $12,937,500 (including the exercise in full of the over-allotment option).

  • CNW Group19 days ago

    Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12

    Cannabis company executives share vision, answer questions live at VirtualInvestorConferences.com NEW YORK , Sept. 6, 2018 /CNW/ -- VirtualinvestorConferences.com and KCSA Strategic Communications today ...

  • CNW Grouplast month

    IIROC Trading Resumption - KHRN

    VANCOUVER , Aug. 23, 2018 /CNW/ - Trading resumes in: Company: Khiron Life Sciences Corp. TSX-Venture Symbol: KHRN Resumption (ET): 10:00 AM IIROC can make a decision to impose a temporary suspension (halt) ...

  • CNW Grouplast month

    Khiron Announces Pricing of Marketed Short Form Prospectus Offering of Common Shares

    TORONTO, Aug. 23, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN , OTCQB:KHRNF), a Canadian integrated medical cannabis company with its core operations in Colombia, is pleased to report that it has priced and sized its previously announced marketed offering of common shares at a price of $0.90 per share to raise aggregate gross proceeds of up to $11,250,000 (the "Offering"). The Offering will be conducted through a syndicate of agents on a best efforts basis led by Canaccord Genuity Corp., and including GMP Securities L.P., Sprott Private Wealth LP, and Cormark Securities Inc. (together, the "Agents").  The Company has also granted the Agents with an over-allotment option to offer and sell up to an additional 15% of the number of common shares sold in the Offering.

  • GlobeNewswirelast month

    Khiron Announces Filing of Marketed Short Form Prospectus Offering of Common Shares

    Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN, OTCQB:KHRNF), a Canadian integrated medical cannabis company with its core operations in Colombia, reports that it has filed a preliminary short form prospectus with the securities regulatory authorities in each of the provinces of Canada, other than Québec, in connection with a marketed offering of common shares of the Company (the “Offering”). The size of the Offering and price will be determined in the context of the market. The Offering will be conducted through a syndicate of agents on a best efforts basis led by Canaccord Genuity Corp., and including GMP Securities L.P., Sprott Private Wealth LP, and Cormark Securities Inc. (together, the “Agents”).  The Company has also granted the Agents with an over-allotment option to offer and sell up to an additional 15% of the number of common shares sold in the Offering.

  • CNW Grouplast month

    IIROC Trading Halt - KHRN

    VANCOUVER , Aug. 21, 2018 /CNW/ - The following issues have been halted by IIROC: Company: Khiron Life Sciences Corp. TSX-Venture Symbol: KHRN Reason: At the Request of the Company Pending News Halt Time ...

  • CNW Grouplast month

    Khiron lists on OTCQB Venture Market

    TORONTO , Aug. 15, 2018 /CNW/ - Khiron Life Sciences Corp. (" Khiron " or the " Company ") (TSXV: KHRN) (OTCQB: KHRNF), a Canadian integrated medical cannabis company with its core ...

  • CNW Grouplast month

    Khiron CEO Alvaro Torres to Speak at Global Cannabis Business Conference in Toronto

    TORONTO, Aug. 13, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that Company co-founder and CEO Mr. Alvaro Torres will participate in an international panel session at the MJBizCon INT'L marijuana business conference, taking place at the Metro Toronto Convention Centre, Aug. 14th – 16th. Mr. Torres will participate in the How to Use Science and Research to Boost Your Business panel session on Thurs., Aug. 16th at 2:00 p.m. Mr. Torres states, "At Khiron we are actively engaging with doctors across Latin America to help them better understand alternative treatments for the medical conditions that are most prevalent in our markets and which can have the most positive social impacts.

  • CNW Group2 months ago

    IIROC Trading Resumption - KHRN

    VANCOUVER , Aug. 7, 2018 /CNW/ - Trading resumes in: Company: Khiron Life Sciences Corp. TSX-Venture Symbol: KHRN Resumption (ET): 15:15 IIROC can make a decision to impose a temporary suspension (halt) ...

  • CNW Group2 months ago

    Khiron Signs Letter of Intent to Acquire Colombia's Leading Health Network

    TORONTO, Aug. 7, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that it has entered into a non-binding letter of intent ("LOI") with the Latin American Institute of Neurology and the Nervous System ("ILANS"), one of the most respected, fastest growing, and largest health service provider networks in Colombia and Latin America. Through the proposed acquisition of the Bogata clinic platform, the ILANS network represents an estimated 100,000 patients, and once closed, will position Khiron with approximately $10.5 million of revenue and $1.8 million of EBITDA (audited for the year ended December 31, 2017).

  • CNW Group2 months ago

    IIROC Trading Halt - KHRN

    VANCOUVER , Aug. 7, 2018 /CNW/ - The following issues have been halted by IIROC: Company: KHIRON LIFE SCIENCES CORP TSX-Venture Symbol: KHRN Reason: At the Request of the Company Pending News Halt Time ...

  • CNW Group2 months ago

    Khiron Expands Medical Cannabis Cultivation Capacity and Advances Towards Commercialization

    TORONTO, Aug. 2, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today it has notified the Colombian Ministry of Justice that the Company has expanded its cultivation area to 17.5 hectares of prime agricultural land near Ibague, Colombia. The cultivation site has an ideal climate profile, abundance of water, power, and skilled labour to scale cultivation and production.

  • CNW Group2 months ago

    IIROC Trading Resumption - KHRN

    VANCOUVER , July 17, 2018 /CNW/ - Trading resumes in: Company: Khiron Life Sciences Corp. TSX-Venture Symbol: KHRN Resumption (ET): 11:30 IIROC can make a decision to impose a temporary suspension (halt) ...

  • CNW Group2 months ago

    Khiron Appoints Former Mexican President Vicente Fox to Board of Directors

    TORONTO, July 17, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that the Company has appointed former President of Mexico Mr. Vicente Fox Quesada to its board of directors, effective immediately. Mr. Fox will be a strategic advisor and brand ambassador for the Company, furthering the Company's education and brand leadership interests across Latin America.

  • CNW Group2 months ago

    IIROC Trading Halt - KHRN

    VANCOUVER , July 16, 2018 /CNW/ - The following issues have been halted by IIROC: Company: Khiron Life Sciences Corp. TSX-Venture Symbol: KHRN Reason: At the Request of the Company Pending News Halt Time ...

  • CNW Group3 months ago

    Khiron Life Sciences Expands CBD-Based Wellness Product Portfolio With Additional Authorizations from Colombian National Food and Drug Surveillance Institute (INVIMA)

    TORONTO , July 5, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia ...

  • CNW Group3 months ago

    Khiron Expands Leadership Team with Appointment of Chris Naprawa as President

    TORONTO, June 26, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today the appointment of Chris Naprawa as President, effective immediately. Mr. Naprawa, who will report to Alvaro Torres, CEO, will lead Khiron's capital markets activities, including outreach to existing and potential shareholders in Canada and internationally.

  • CNW Group3 months ago

    Khiron Appoints Internationally Recognized Medical Cannabis Specialist Dr. Maria Fernanda Arboleda as Medical Director

    TORONTO, June 25, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that it has appointed Dr. Maria Fernanda Arboleda as Medical Director.

  • CNW Group3 months ago

    Khiron Life Sciences Corp. Applauds Election of Iván Duque as President of Colombia

    TORONTO, June 21, 2018 /CNW/ - Khiron life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, wishes to congratulate President-Elect, Iván Duque of the Democratic Centre party, on winning the election on June 17, 2018 to become the next federal leader of Colombia. Mr. Duque will take over from incumbent President Juan Manuel Santos in August.

  • CNW Group3 months ago

    Khiron VP, Compliance Matt Murphy Appears on CBS Network's 60 Minutes to Discuss Law Enforcement and the Global Opioid Crisis

    TORONTO, June 19, 2018 /CNW/ - Khiron Life Sciences Corp. (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that its newly appointed Vice President of Compliance, Matt Murphy, appeared on CBS Network's June 17, 2018 airing of 60 Minutes to discuss important aspects of the U.S. opioid crisis. Murphy and other senior U.S. Drug Enforcement Administration (DEA) agents revealed in the program detailed investigative accounts that expose a failure by the U.S. pharmaceutical industry to regulate itself and stem the massive flow of opioid-based painkillers into the consumer marketplace.

  • CNW Group3 months ago

    Khiron Forms Exclusive Strategic Alliance with ILANS, Expanding Distribution Network to Over 500,000 Patients

    TORONTO, June 14, 2018 /CNW/ - Khiron life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that the Company has formed an exclusive strategic alliance with Latin American Institute of Neurology and the Nervous System ("ILANS"), one of the most respected, fastest growing, and largest health service provider networks in Colombia and Latin America. ILANS represents an estimated 100,000 patients, with the majority of these patients being located in Colombia.

  • CNW Group3 months ago

    Khiron Achieves Key Milestone in Mission to Become First Medical Cannabis Company to Bring Products to Market in Colombia

    Colombian Agricultural Institute ("ICA") authorization is a significant requirement to cultivate and distribute medical cannabis in Colombia. TORONTO, June 13, 2018 /CNW/ - Khiron life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that the Company has been registered by the Colombian Agricultural Institute ("ICA") as an agronomical unit.

  • Baystreet3 months ago

    Stocks in play: Khiron Life Sciences Corp.

    Has received endorsements and signed co-operation agreements with two of the largest and most recognized ...